Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ABRAXANE | Paclitaxel | injection, powder, lyophilized, for suspension, intravenous | 68817-134NDA |
Compare
Other companies listing paclitaxel
- Hetero Labs Limited8 sites · 167 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Fresenius Kabi USA, LLC6 sites · 561 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- NATCO PHARMA LIMITED5 sites · 108 NDC
- American Regent, Inc.5 sites · 70 NDC
- Indena SpA2 sites · 15 NDC
- Phyton Biotech, GmbH2 sites · 2 NDC
Enquiry
Common questions
- Is Abraxis BioScience, LLC FDA approved?
- Abraxis BioScience, LLC holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Abraxis BioScience, LLC make?
- 1 product is listed under Abraxis BioScience, LLC in the openFDA NDC Directory, most often as injection, powder, lyophilized, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.